type 2 diabetes mellitus Clinical Trials
A listing of type 2 diabetes mellitus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 23 clinical trials
UPENN Case Test Trial 1 In Different Account (Do Not Make Any Change)
UPENN Case Test Trial 1 In Different Account (Do Not Make Any Changes)
- 0 views
- 02 Sep, 2025
- 2 locations
“The Shift Worker’s Microbiome”
Individuals who work night shifts or rotating shift schedules are more likely to develop cardiovascular disease (stroke and heart attack) and diabetes (high blood sugar). This is thought to be related to the long-term disruption of these workers’ body clocks associated with changing or nighttime schedules.
- 0 views
- 19 Feb, 2024
- 1 location
Research Study for women with PCOS (Polycystic ovary syndrome)
Healthy women ages 18-45 with Polycystic Ovary Syndrome (PCOS) are invited to screen for a study participation in an investigational drug study
- 0 views
- 19 Feb, 2024
- 1 location
Normal Donor Human Bone Marrow Donation for Research
We are looking for healthy volunteers to donate bone marrow for research purposes. The Stem Cell & Xenograft Core provides bone marrow to laboratories on Penn’s campus researching leukemia and other blood disorders
- 0 views
- 19 Feb, 2024
- 1 location
Comparison of the Short-Term Effect of Dietary Carbohydrate Restriction Versus Exogenous Ketone Supplementation on Myocardial Glucose Suppression and Timing to Achieve a State of Ketosis Using FDG PET/CT Serial Imaging
We will enroll up to 50 subjects in order to reach our target of 40 fully evaluable; 20 healthy volunteers and 20 patients with Type 2 diabetes mellitus. We will test whether dietary modification (ketogenic diet) or exogenous ketone administration will provide enhanced myocardial glucose suppression.
- 0 views
- 19 Feb, 2024
- 1 location
Effect of GLP-1 Agonist Therapy on Insulin Secretion in Adults with Pancreatic Insufficient Cystic Fibrosis and Abnormal Glucose Tolerance: a randomized open-label cross-over trial
Diabetes is a major co-morbidity in pancreatic insufficient cystic fibrosis (PI-CF) and associated with worse outcomes. While reduced -cell mass contributes to the insulin secretory defects that characterizes cystic fibrosis-related diabetes (CFRD), other modifiable determinants appear operative in the emergence and progression of abnormal glucose tolerance towards diabetes.
- 0 views
- 19 Feb, 2024
- 1 location